NRP1 and non-small cell lung carcinoma: Coexpression of NRP1 and NRP2 also increases in the progression from dysplasia to microinvasive lung carcinoma, and correlates significantly with tumour progression and poor prognosis in patients with non-small-cell lung carcinoma (Kawakami et al, 2002).